Results 241 to 250 of about 1,989,460 (302)

Hyperglycemia and systemic inflammation differentially shape immune dysregulation, tissue destruction, and microbiota in experimental periodontitis and peri-implantitis in diabetic mice. [PDF]

Front Immunol
Memida T, Jaar JC, Chen T, Cao G, Kuriki N, Abdolahinia ED, Okamoto M, Shindo S, Yamashita S, He X, Suzuki M, Vardar S, Kawai T, Han X.   +13 more
europepmc   +1 more source

Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application. [PDF]

Materials (Basel)
Phan TNL, Truong TT, Vo TH, Pham VH, Nguyen TX, Duong TKN, Doan VHM, Choi J, Misra M, Oh J, Mondal S.   +10 more
europepmc   +1 more source

Hybrid Versus Moderate Rough Implants in Periodontally Compromised Patients: A Randomized Controlled Split-Mouth Study. [PDF]

Clin Implant Dent Relat Res
Dank A, Wismeijer D, van Elsas P, Tribst JM, Su N, Feilzer A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug delivery from ocular implants

Expert Opinion on Drug Delivery, 2006
Developing an intraocular drug delivery system (DDS) is urgently needed because most vitreoretinal diseases are refractory to conventional pharmacological approaches; eye drops and systemically administered drugs cannot deliver therapeutic drug concentrations into vitreoretinal tissue. Intraocular DDSs address this problem.
Tsutomu Yasukawa, Yuichiro Ogura
exaly   +3 more sources

Drug-Eluting Implants for Osteomyelitis

Critical Reviews™ in Therapeutic Drug Carrier Systems, 2007
Osteomyelitis, an inflammatory process accompanied by bone destruction, is caused by infective microorganisms. The high success rates of antimicrobial therapy by conventional routes of administration in controlling most infectious diseases have not yet been achieved with osteomyelitis for several reasons.
Chidambaram, Soundrapandian, Someswar, Datta, Biswanath, Sa   +2 more
openaire   +2 more sources

Drug-Eluting Medical Implants

2009
Drug-eluting medical implants are actually active implants that induce healing effects, in addition to their regular task of support. This effect is achieved by controlled release of active pharmaceutical ingredients (API) into the surrounding tissue.
Meital, Zilberman, Amir, Kraitzer, Orly, Grinberg, Jonathan J, Elsner   +3 more
openaire   +2 more sources

Implantable Drug-Delivery Systems

Scientific American, 1979
Implantable drug-delivery systems are being developed to release drugs to the bloodstream continuously as well as free patients from being hospitalized to receive intravenous infusions or frequent injections. One technique is implantation of a pellet in the subcutaneous tissue so the pellet may be released by erosion.
openaire   +2 more sources

Implantable pumps for drug delivery to the brain

Journal of Neuro-Oncology, 1995
This article reviews the role of implantable pumps in the treatment of CNS tumors. Systemic administration of chemotherapeutic agents has been associated with various problems, including adverse systemic effects and decreased concentration of the drug at the target site.
S, Bakhshi, R B, North
openaire   +2 more sources